Beverage Giant Pops on Strong Earnings

Author

Adam Garcia
February 11, 2025

Presented by

A beverage giant is surging on strong earnings, an e-commerce firm is sliding after giving weak profit guidance despite its solid holiday sales, and a biotech stock is up 50%+ after trial results on its lead candidate came out positive. Read on to find out more.

📲 Want our updates via text message? Get Elite Trade Club's pre-market insights and hottest stocks straight to your cell for 100% free. Click here to sign up.

Technology (Sponsored)

This tech company grew 32,481%...

No, it's not Nvidia... It's Mode Mobile, 2023’s fastest-growing software company according to Deloitte.

Just as Uber turned vehicles into income-generating assets, Mode is turning smartphones into an easy passive income source, already helping 45M+ users earn $325M+ through simple, everyday use.

They’ve just been granted their stock ticker by the Nasdaq, and you can still invest in their pre-IPO offering at just $0.26/share.

*Mode Mobile recently received their ticker reservation with Nasdaq ($MODE), indicating an intent to IPO in the next 24 months. An intent to IPO is no guarantee that an actual IPO will occur.
*The Deloitte rankings are based on submitted applications and public company database research, with winners selected based on their fiscal-year revenue growth percentage over a three-year period.
*Please read the offering circular and related risks at invest.modemobile.com.

Futures 📈

What to Watch

Earnings:

  • DoorDash, Inc. [DASH]: Aftermarket 

  • Energy Transfer LP [ET]: Aftermarket

  • Gilead Sciences, Inc. [GILD]: Aftermarket

  • Welltower Inc. REIT [WELL]: Aftermarket

Economic Reports:

  • NFIB optimism index [Jan]: 6:00 a.m.

Food & Beverages

Coca-Cola Shares Rising in Premarket Trading After Strong Q4 Showing

Coca-Cola [KO] posted strong fourth-quarter results, with revenue rising 6% year-over-year to $11.5 billion, surpassing analyst expectations.

The company’s net income climbed 11% to $2.2 billion, while diluted earnings per share (EPS) increased by 12% to $0.51.

Operating income for the quarter also saw a sharp 19% rise, reaching $2.7 billion.

For the full year 2024, Coca-Cola posted a 3% increase in net operating revenue, totaling $47.1 billion. Despite the revenue growth, diluted EPS for the year remained steady at $2.46.

CEO James Quincey attributed the company’s performance to its ability to navigate shifting market conditions.

"Our all-weather strategy is working, and we continue to demonstrate our ability to lead through dynamic external environments," he said.

Coca-Cola’s shares are up 3.5% in premarket trade, with investors responding positively to the company’s solid financial performance and its ability to drive growth despite economic challenges.

Hotels

Marriott’s Q4 Revenue Above Expectations, But 2025 Guidance is Weak

Source: Raysonho @ Open Grid Scheduler / Grid Engine, CC0, via Wikimedia Commons

Marriott International [MAR] projects lower-than-expected profit for 2025, citing weaker performance in its Greater China market.

The company now expects adjusted earnings per share (EPS) to range between $9.82 and $10.19 for the year, falling short of Wall Street’s forecast of $10.65.

Marriott shares are declining by 1.6% in premarket trading.

The hotel operator has faced headwinds in China, where domestic travel demand has softened due to economic uncertainty, job security concerns, and wage pressures.

Revenue per available room (RevPAR) in Greater China declined by 1.8% in the fourth quarter, reflecting a slowdown in consumer spending.

Despite the weaker guidance, Marriott’s fourth-quarter revenue is $6.43 billion, slightly exceeding analyst estimates of $6.38 billion.

While international travel demand remains strong in other regions, the company’s struggles in China highlight the ongoing challenges in the world’s second-largest economy.

Marriott remains focused on expanding its portfolio and optimizing operations, but investors are watching closely to see how the company navigates slower demand in key Asian markets.

The mixed earnings report reflects broader concerns over global travel trends heading into 2025.

Air Travel (Sponsored)

Looking for the next big EV opportunity?

Find out more about this potential game-changer.

E-Commerce

Shopify Q4 Sales Above Expectations, But Weak Forecast is Causing Shares to Slide

Source: Raysonho @ Open Grid Scheduler / Grid Engine, CC0, via Wikimedia Commons

Shopify [SHOP] reported better-than-expected fourth-quarter sales, but a weaker-than-hoped profit outlook for the first quarter is weighing on investor sentiment.

Despite a 31% revenue jump to $2.81 billion—its fastest growth in six quarters—Shopify’s stock is down 6% in premarket trading today.

The e-commerce giant has been expanding its AI-powered services, rolling out tools such as “Shopify Magic” and the Sidekick AI assistant.

These tools are designed to help merchants with tasks like inventory management, image generation, and customer analytics.

AI features have driven more small- and medium-sized businesses to the platform, boosting gross merchandise volume by 26% to $94.46 billion in the holiday quarter.

However, these advancements have also led to increased costs.

Shopify expects gross profit dollars to grow at a low-twenties percentage rate in Q1, trailing the 24.2% anticipated by analysts.

Operating expenses as a percentage of revenue are projected to rise to 41%-42%, up from 31.5% in the previous quarter.

While the company forecasts mid-twenties percentage growth in Q1 revenue—aligning with analyst expectations for a 24.4% increase—investors remain cautious about its ability to maintain profitability amid rising expenses.

Movers and Shakers

Lipella Pharmaceuticals Inc. [LIPO] - Last Close: $3.05

Lipella Pharmaceuticals is a clinical-stage biotech company developing therapies for inflammatory and rare diseases.

Its shares are surging 50%+ premarket after the company reported positive safety results for its lead candidate LP-310 in a 24-patient study.

My Take: If LP-310 secures FDA approval, it could be a big moment for Lipella. However, until then this is a clinical stage firm with a high risk profile, and investors should weigh carefully before putting their money here.

Firefly Neuroscience, Inc. [AIFF] - Last Close: $3.10

Firefly Neuroscience is an AI-driven medtech company focused on improving brain health outcomes through its FDA-cleared Brain Network Analytics (BNA™) platform.

Its shares are rising in early trade after announcing its acceptance into NVIDIA’s Connect program, which will grant the company access to cutting-edge AI tools, hardware, and software.

My Take: Acceptance into NVIDIA’s program is a major validation of Firefly’s approach, but its tech is still experimental, so it might be best to adopt a wait and watch strategy here.

SelectQuote, Inc. [SLQT] - Last Close: $4.38

SelectQuote is a technology-driven insurance distribution platform.

Its shares are soaring 33% in premarket trading after securing a $350 million strategic investment from Bain Capital, Morgan Stanley Private Credit, and Newlight Partners.

My Take: Strategic backing from major investors is a huge positive for SLQT but the firm has struggled with profitability in recent quarters, so be cautious while investing here.

Tesla of Skies (Sponsored)

This company is leading the charge with its innovative approach to electrification and strong industry ties.

Everything Else

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

📧 Like newsletters? Here are some newsletters our readers also enjoy. Explore

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

*Standard message/carrier rates may apply.

Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.